Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P lindenmayer

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Journal De Genetique Humaine|May 1, 1970
[Heredity of familial oxalosis]J P Lindenmayer
The Psychiatric Quarterly|October 12, 2000
Treatment refractory schizophreniaJ P Lindenmayer
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1995
New pharmacotherapeutic modalities for negative symptoms in psychosisJ P Lindenmayer
Neuropsychiatric Disease and Treatment|July 15, 2010
Long-acting injectable antipsychotics: focus on olanzapine pamoateJ P Lindenmayer
The Journal of Clinical Psychiatry|January 12, 2001
The pathophysiology of agitationJ P Lindenmayer
The Journal of Clinical Psychiatry|July 22, 1998
Olanzapine-induced manic-like syndromeJ P Lindenmayer, R Klebanov
Expert Review of Neurotherapeutics|April 28, 2005
Pharmacological treatment strategies for schizophreniaJ P Lindenmayer, Anzalee Khan
Journal of Clinical Psychopharmacology|June 1, 1999
Schizophrenia and schizoaffective disorder treated with high doses of olanzapineA Fanous, J P Lindenmayer
The American Journal of Psychiatry|September 15, 1999
Olanzapine-induced ketoacidosis with diabetes mellitusJ P Lindenmayer, R Patel
The Journal of Clinical Psychiatry|April 1, 1981
Toxic psychosis following use of quinacrineJ P Lindenmayer, P Vargas
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Journal De Genetique Humaine|May 1, 1970
[Heredity of familial oxalosis]J P Lindenmayer
The Psychiatric Quarterly|October 12, 2000
Treatment refractory schizophreniaJ P Lindenmayer
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1995
New pharmacotherapeutic modalities for negative symptoms in psychosisJ P Lindenmayer
Neuropsychiatric Disease and Treatment|July 15, 2010
Long-acting injectable antipsychotics: focus on olanzapine pamoateJ P Lindenmayer
The Journal of Clinical Psychiatry|January 12, 2001
The pathophysiology of agitationJ P Lindenmayer
The Journal of Clinical Psychiatry|July 22, 1998
Olanzapine-induced manic-like syndromeJ P Lindenmayer, R Klebanov
Expert Review of Neurotherapeutics|April 28, 2005
Pharmacological treatment strategies for schizophreniaJ P Lindenmayer, Anzalee Khan
Journal of Clinical Psychopharmacology|June 1, 1999
Schizophrenia and schizoaffective disorder treated with high doses of olanzapineA Fanous, J P Lindenmayer
The American Journal of Psychiatry|September 15, 1999
Olanzapine-induced ketoacidosis with diabetes mellitusJ P Lindenmayer, R Patel
The Journal of Clinical Psychiatry|April 1, 1981
Toxic psychosis following use of quinacrineJ P Lindenmayer, P Vargas
Pageof 8